Editorial Board
Masayoshi Yamaguchi
Department of Hematology and Medical Oncology, Emory University School of Medicine · United States
Editorial leadership for Journal of DNA And RNA Research ISSN 2575-7881
Research interests
- Dr. Yamaguchi Is Engaged In The Fields Of Endocrinology
- Cell Signaling Since 1971
- And These Researches Are Developed In The Aspect Of Biochemistry
- Molecular Biology
- Endocrinology
- Metabolism
- Nutrition
- Pharmacology
- And Toxicology.&Nbsp; Dr. Yamaguchi Has An Interesting For Cell Signaling Mechanism
- Bone Biology
- Nutritional Factor
- Osteoporosis Prevention
- Diabetes
- Diabetic Osteoporosis
- Cell Signaling
- Cancer Biology
- And Cancer Bone Metastasis.&Nbsp; He Also Discovered Two Novel Proteins
- Genes;&Nbsp; Cell Signaling Suppressor Protein (Named Regucalcin; 1978)&Nbsp; Transcriptional Factor Rgpr-P117 (Regucalcin Gene Promoter Region-Related Protein; 2001) In Mammalian Cells
Biography
- Dr. Masayoshi Yamaguchi is presently working as a Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, USA.
- He also worked as Visiting Professor in the departments of Foods and Nutrition, Diabetes, Endocrinology, Metabolism, Pathobiology and also worked as Professor in the department of Nutritional Sciences.
- He had registered over 20 national and international patents in the fields of his research interesting.
Honor and awards:
- The Distinguished Service to Science Award from IBC (2007, England),
- Japan Society for Biomedical Research on Trace Elements Award 2007,
- International Biographical Dictionary (2006, IBC, England),
- Who’s Who in the World (2005, Marquis Who’s Who, USA),
- The Lifetime Achievement Award from International Biographical Centre (IBC) (2004, England),
- The World Lifetime Achievement Award from American Biographical Institute (2004, USA).
- He is serving as editors and editorial board members of reputed 60 international Journals.
Considering JDRR for your work?
This journal is guided by Masayoshi Yamaguchi (Department of Hematology and Medical Oncology, Emory University School of Medicine) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.